Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study;Srovnání adjuvantní chemoterapie karcinomu prsu kombinací cyklofosfamid, metotrexat, 5-fluorouracil (CMF) a AC (doxorubicin, cyklofosfamid). První výsledky národní kooperativní studie.

Sborník lékarský

Volumn 99, Issue 1, 1998, Pages 25-31

  Pribylova O ^a   Petruzelka, L ^a   Honova H ^a   Fischer, J ^a   Bustova I ^a   Siffnerova H ^a   Kuta M ^a   Miller, V ^a   Hacklova M ^a   Machacek J ^a   Kohoutek, M ^a   Vodvarka P ^a   Kysela T ^a   Tajblova J ^a   Suk, J ^a   Dorazilova V ^a   Bauer, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AC PROTOCOL; ANTINEOPLASTIC AGENT; CMF REGIMEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; CARCINOMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; PROSPECTIVE STUDIES;

EID: 0031608935     PISSN: 00365327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)